© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Besifloxacin Hydrochloride belongs to the family of fluoroquinolone antibacterial agents, crafted specifically for topical use in ophthalmology. This molecule comes from advanced synthetic chemistry, where the fusion of distinct aromatic rings and fluorine enhancements creates a compound known for its broad-spectrum action against bacterial pathogens. The typical product emerges as a fine to slightly granular powder, often white to pale yellowish in shade. This shade signals a high level of purity, with only trace impurities visible, usually documented in its detailed product specification sheets. On the sensory side, the solid usually offers no significant odor and shows stability at room temperature, ensuring practicality in storage and shipment. For the pharmaceutical chemist, the feel, flow, and behavior of the powder during formulation become predictable and reliable, making it a frequent choice for ophthalmic suspensions and solutions.
From a chemistry viewpoint, Besifloxacin Hydrochloride showcases a complex molecular architecture. Its formula, C19H21ClFN3O3•HCl, yields a molecular weight typically calculated at 442.3 g/mol. The architectural backbone relies on a robust quinolone core, with a fluorine atom enhancing membrane penetration and a chlorine atom boosting antibacterial potency. Analytical chemists pay attention to its crystalline structure, where the hydrochloride salt form ensures better solubility and handling compared to base counterparts. X-ray diffraction and spectroscopy studies report highly ordered crystals, confirming stability across a range of environmental conditions. Specific gravity measurements usually place the solid’s density near 1.5 g/cm³, a useful figure for manufacturing calculations and dosing accuracy. This material resists melting until temperatures exceed 220°C, and solubility indices point to good dissolution in aqueous acidic solutions—critical for formulation scientists working with ophthalmic preparations.
Manufacturers produce Besifloxacin Hydrochloride in a range of batches following tight chemical and biological standards, with the purity usually stated at more than 99% on a dry basis. Lots are analyzed for heavy metal content, water content, and residual solvents, reflecting a global push for pharmaceutical safety and environmental stewardship. The material appears in physical forms such as flakes, dense powder, or fine crystalline solids; form selection often depends on application or packaging needs. Specification sheets regularly list minute details such as particle size distribution, color range under daylight bulbs, moisture percentages, and solubility figures for both water and key organic solvents. Such precision makes a difference both at the laboratory scale and on the production line, where batch variability must drop to near zero for medical consistency. Besifloxacin Hydrochloride rarely takes liquid form in commerce, since the pure chemical remains most practical as a stable, easy-to-weigh solid.
Global commerce of Besifloxacin Hydrochloride leans on the World Customs Organization’s HS Code for tracking. This substance usually travels under classification 2941.90 (Antibiotics, not elsewhere specified or included), a code common to customs agents, shippers, and global buyers. Warehousing professionals often log batch numbers, purity levels, and storage temperatures for compliance, with documentation including safety data in several languages. Packing bulk powder in fiber drums lined with polyethylene, or in high-density polyethylene bottles, reduces contamination risk and ensures stable shelf life. Documentation requirements increase with value and sensitivity, involving country-of-origin certificates and closed shipping containers on international routes. Reliable suppliers work through a regulated chain of custody, minimizing loss or deviation in shipment and providing real-time updates for quality assurance officers.
Besifloxacin Hydrochloride, being synthetic and potent, brings strict safety protocols. While the molecule delivers powerful activity against bacterial DNA gyrase, it shows irritant tendencies in dust and powder form if mishandled. Laboratories and production plants operate with enclosed transfer systems, chemical-resistant gloves, and particulate respirators, reducing exposure to airborne dust. Spills of the powder warrant careful, damp-wipe cleanup, not dry sweeping, to prevent inhalation. Environmental teams review spill containment and waste management policies to prevent the chemical’s escape into municipal water systems. This compound falls under controlled handling status in many nations, as its potent pharmacology makes accidental distribution or misuse a genuine public health concern. Material safety data lays out firefighting guidance (dry powder or CO₂ extinguishers recommended) and first-aid steps in the event of skin or eye contact. Chemists and technicians consistently check expiration dates, monitoring for any color or texture shifts that suggest decomposition or hydration—procedures deeply tied to good manufacturing practices.
In material science, Besifloxacin Hydrochloride’s crystalline phases and robust, moisture-resistant structure matter as much as its antibiotic utility. Pure crystalline forms enable accurate weighing and homogenous dispersion in ophthalmic vehicle suspensions or gels, minimizing formulation headaches during scale-up. The hydrochloride salt imparts stability by suppressing ionization drift, a property beneficial in sensitive applications like single-dose eye drops or ointments. Scientists measuring solubility, pH response, and buffer compatibility rely on established European and US pharmacopeia tests, uncovering subtle shifts that can affect patient response or shelf stability. Raw material managers push for assays every lot, supporting traceability from source to final medicine. Its chemical characteristics tie back to molecular design—those fluorine and chlorine modifications mean not just improved action in the body but also resistance to light and humidity, both critical for open-vial performance in real hospital settings.
Besifloxacin Hydrochloride stands as a high-value antibiotic ingredient, anchored in chemistry and pharmaceutical manufacturing. Demand continues to rise, but the balance between clinical benefit and environmental safety pushes companies to adopt closed-system production and stricter waste control. Researchers inspect alternatives and derivatives, but current data keeps this molecule in top demand for ocular therapy. With advances in automation and real-time batch monitoring, factories funnel lab-tested product direct to compounding lines. End-users, from pharmacists to clinicians, depend on clear safety sheets and unbroken cold chains for peace of mind. This compound, born in the lab but perfected through quality assurance, serves as a textbook example of how raw material properties, regulatory oversight, and frontline application intersect in today’s chemical and pharmaceutical industries.
